IP Library Granted Patent US 8,624,026
Granted Patent B2
US 8,624,026 · App. 13/502,260 · Granted Jan 7, 2014

Method of preparing sitagliptin and intermediates used therein

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,624,026
App. No.
13/502,260
Granted
Jan 7, 2014
Kind
B2
Abstract

Disclosed are a novel, simple and low-cost method for preparing sitagliptin of formula (I), as DPP-IV (dipeptidyl peptidase IV) inhibitor, which is useful in treating type 2 diabetes mellitus and key intermediates used in said preparation of sitagliptin:

Claims (11)

1. A method of preparing sitagliptin of formula (I), which comprises the steps of:

(i) allowing (S)-epichlorohydrin to undergo arylation, epoxidation, and vinylation reactions to obtain (2R)-1-(2,4,5-trifluorophenyl)-4-penten-2-ol of formula (II);

(ii) azidatizing the compound of formula (II) to obtain (2S)-1-(2-azido-4-pentenyl)-2,4,5-trifluorobenzene of formula (III);

(iii) oxidizing the compound of formula (III) to obtain (3R)-3-azido-4-(2,4,5-trifluorophenyl)-butyric acid of formula (IV);

(iv) condensing the compound of formula (IV) with 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride of formula (VI) to obtain (3R)-3-azido-1-(3-trifluoromethyl)-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)-butan-1-one of formula (V); and

(v) reducing the azido group of (3R)-3-azido-1-(3-trifluoromethyl)-5,6-dihyrdro-8H-[1,2,4]-triazolo[4,3-a]pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)-butan-1-one of formula (V) to obtain sitagliptin of formula (I):

2. The method of claim 1 , wherein step (ii) is conducted in the presence of an activator selected from the group consisting of mesyl chloride, p-tosyl chloride, benzenesulfonyl chloride, trifluoromethansulfonyl chloride, and a mixture thereof.

3. The method of claim 1 , wherein the oxidant used in step (iii) is selected from the group consisting of NaIO 4 , NaMnO 4 , KMnO 4 , H 2 CrO 4 , OsO 4 , NaOCl, and a mixture thereof.

4. The method of claim 1 , wherein step (iii) is conducted in the presence of a catalyst selected from the group consisting of RuCl 3 , RuO 4 , OsO 4 , KMnO 4 , and a mixture thereof.

5. The method of claim 1 , wherein step (v) is conducted using a reductant selected from the group consisting of a mixture of PPh 3 and H 2 O, a mixture of PPh 3 and HCl, a mixture of PPh 3 and NH 4 OH, and a mixture of PPh 3 and H 2 S.

6. The method of claim 1 , wherein step (v) is conducted using a reductant selected from the group consisting of hydrogen, HCOOH, NH 4 OH, NH 2 NH 2 , BH 3 , NaBH 4 , a mixture of Zn and HCl, and a combination thereof, in the presence of a metallic catalyst selected from the group consisting of Raney Ni, Pd, Pt, Pd/C, Pd/Al 2 O 3 , Pd(OH) 2 /C, and a mixture thereof.

Assignments (2)
CHANGE OF NAME Recorded Aug 3, 2012
From: HANMI HOLDINGS CO., LTD.
To: HANMI SCIENCE CO., LTD.
Reel/Frame 028722/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2012
From: KIM, NAM DU; CHANG, JI YEON; KIM, DONG JUN; LEE, HYUN SEUNG; JUNG, JAE HYUK; CHANG, YOUNG KIL; LEE, GWAN SUN
To: HANMI HOLDINGS CO., LTD.
Reel/Frame 028052/0540 →